Medical Toxicology Foundation Research Award:
Prescription Drug Abuse Prevention
Misuse and abuse of prescription opioids, stimulants, and sedative medications has reached epidemic proportions in the United States. Overdose is now the leading cause of unintentional injury death, and most of these deaths are caused by prescription medications.
The MTF will support outstanding research and other initiatives that have the potential to reduce the misuse and abuse of prescription drugs, particularly among young people. A major goal is to support the development and/or analysis of innovative prevention, treatment, and/or harm reduction strategies.
The maximum amount of this award is $5,000 for direct costs. By policy, the MTF does not cover indirect costs. The maximum award period is two years and will be offered again in 2019.
Check back Fall 2018 for submission guidelines.
2015 MTF Prescription Drug Abuse Prevention Award
PI: Rachel Wightman, MD, PGY4 Emergency Medicine Resident, New York University/Bellevue, New York, NY
Protocol: Helping enhance targeted opioid harm reduction efforts through Erowid.
Wightman et al. Comparative analysis of trends in opioid queries on the Erowid website 2009-2015. J Med Toxicol 2016;12:7 (abstract #11)
Wightman et al. Relative frequency of unique opioid visits versus heroin on Erowid.org. J Med Toxicol 2016;12:7-8 (abstract #12)
2014 MTF Prescription Drug Abuse Prevention Award
PI: Katherine Boyle, MD, Division of Medical Toxicology, Department of Emergency Medicine, University of Massachusetts Medical School, Worcester, MA
Protocol: Teaching Effective Opioid Prescribing Through a Simulation Curriculum
Abstract: i. Boyle et al. Teaching effective opioid prescribing through a simulation curriculum. J Med Toxicol 2016;12:39-40 (abstract #109)